Gregg Eure

Urology of Virginia

Papers

3

Total Citations

136

H-Index

3

About

Dr. Gregg Eure is a leading urologic surgeon whose research has fundamentally advanced the treatment of benign prostatic hyperplasia (BPH), particularly for patients with large prostates. His work centers on the development and validation of Aquablation therapy, a minimally invasive, robotically guided waterjet procedure. Dr. Eure’s major contribution is providing the long-term evidence that Aquablation is both safe and highly effective for men with prostate volumes between 80 and 150 cc—a group historically challenging to treat. His landmark publications, including the 1-year and final 5-year results of the pivotal WATER II clinical trial (with 63 and 49 citations, respectively), demonstrate durable symptom relief and low complication rates. These studies, which tracked over 100 men, have established Aquablation as a gold-standard option for large-gland BPH, offering a powerful alternative to more invasive surgery. With his work cited hundreds of times and shaping international treatment guidelines, Dr. Eure’s research has directly improved outcomes and quality of life for countless patients worldwide.

Research Focus

Key Achievements

3
H-Index
3
Papers
136
Total Citations
45
Avg Citations/Paper
🏆 Most Cited Paper
Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results
63 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 29
🏛 Institutions: Urology of Virginia

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago